Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / C••••• S•••••••• H•••••••• I•••

C••••• S•••••••• H•••••••• I•••

Stage unknownRed Bank, NJBiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
5
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
5 rounds
  1. Jul 25, 2025
    Form D equity offering · $1.2M (form d sold) · 6 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “C••••• S•••••••• H•••••••• I••• filed Form D: $1,225,003 sold of $1,225,003, Biotechnology”
  2. Jul 23, 2025
    Form D equity offering · $1.7M (form d sold) · 13 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “C••••• S•••••••• H•••••••• I••• filed Form D: $1,740,000 sold of $1,740,000, Biotechnology”
  3. Jun 13, 2025
    Form D equity offering · $2.5M (form d sold) · 30 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Tharimmune, Inc. filed Form D: $2,500,000 sold of $2,500,000, Biotechnology”
  4. Dec 9, 2024
    Form D equity offering · $2.0M (form d sold) · 7 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Tharimmune, Inc. filed Form D: $2,020,000 sold of $2,020,000, Biotechnology”
  5. Jun 18, 2024
    Form D equity offering · $2.1M (form d sold) · 5 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Tharimmune, Inc. filed Form D: $2,084,160 sold of $2,084,160, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
9 officers, 12 directors
Timeline
5
  1. Apr 15, 2026
    C••••• S•••••••• H•••••••• I••• filed Form D: $1,225,003 sold of $1,225,003, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Apr 15, 2026
    C••••• S•••••••• H•••••••• I••• filed Form D: $1,740,000 sold of $1,740,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  3. Jul 7, 2025
    Tharimmune, Inc. filed Form D: $2,500,000 sold of $2,500,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  4. Dec 17, 2024
    Tharimmune, Inc. filed Form D: $2,020,000 sold of $2,020,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  5. Jun 28, 2024
    Tharimmune, Inc. filed Form D: $2,084,160 sold of $2,084,160, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
60 observations
Every observation on this company